MedTrace Logo

Pharmacist-Led Intervention to Improve TB Treatment Adherence

NCT06608069 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 383

Last updated 2025-08-07

No results posted yet for this study

Summary

The goal of this clinical trial is to compare the adherence of co-morbid patients in control and experimental group

The main question\[s\]it aims to answer are:

1. To evaluate the impact of pharmacist-led educational intervention on treatment adherence among patients with PTB using the health belief model theory and MARS-5.
2. To evaluate the impact of pharmacist-led educational intervention on treatment outcomes among patients with PTB.
3. To evaluate the impact of pharmacist-led educational intervention on HRQoL among patients with PTB.

Participants will be interviewed to measure the level of adherence.

If there is a comparison group:

The enrolled patient will be counselled and educated by the pharmacist on the therapy and the benefits of adherence (Control group).

Enrolled participants will be counselled and educated by pharmacist on the therapy and benefits of adherence. (Experimental group).

Conditions

  • Tuberculosis, Pulmonary
  • HIV Coinfection

Interventions

BEHAVIORAL

Educational counselling

Enrolled participants will be counselled and educated by pharmacist on the therapy and benefits of adherence.

Sponsors & Collaborators

  • Universiti Sains Malaysia

    lead OTHER

Principal Investigators

  • Aner H Khan · Universiti Sains Malaysia

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2024-09-01
Completion
2025-02-01

Countries

  • Malaysia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06608069 on ClinicalTrials.gov